摘要
Objective To investigate in-vitro activity of tigecycline against common clinical multidrug resistant(MDR) bacteria.Methods The MDR bacteria(except Pseudomonas aeruginosa) were collected retrospectively from 2009 to 2010 in 15 hospitals from 11 cities.The MIC of
